Dosidal · Switzerland
Nexviadyme, poudre pour solution à diluer pour perfusion
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:67871 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 67871 atc: A16AB22 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2021-11-17 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: A16AB22 authorisation_number: 67871 form: PULPI holder: Sanofi-Aventis (Suisse) SA holder_partner_nr: 1005874 it_number: 07.14.0. name: Nexviadyme, poudre pour solution à diluer pour perfusion state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d536Nl0IMoMdM88R_89V-JnOqAqGwmVq5hvznS55KlawddNGOW0CQ5qhTl-6r7_9RZqG8IhkPjbzYcD1tIRY93OJwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |